share_log

天齊鋰業：海外監管公告 - 關於增發公司H股股份一般性授權的公告

TIANQI LITHIUM: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section

香港交易所 ·  Mar 27 18:53
Summary by Moomoo AI
天齊鋰業股份有限公司於2024年3月27日召開董事會，通過增發公司H股股份一般性授權的議案。此舉旨在滿足公司業務發展需求，擬授權董事會及董事長決定發行不超過已發行股份總數20%的H股或相關證券。該授權包括決定發行新股的條款及條件，如股份類別、數目、定價方式、發行日期等。該一般性授權的有效期至2023年度股東大會通過後的12個月、2024年度股東大會結束日或股東會撤銷或修訂授權之日為止。此項增發方案尚需提交至2023年度股東大會審議。
天齊鋰業股份有限公司於2024年3月27日召開董事會，通過增發公司H股股份一般性授權的議案。此舉旨在滿足公司業務發展需求，擬授權董事會及董事長決定發行不超過已發行股份總數20%的H股或相關證券。該授權包括決定發行新股的條款及條件，如股份類別、數目、定價方式、發行日期等。該一般性授權的有效期至2023年度股東大會通過後的12個月、2024年度股東大會結束日或股東會撤銷或修訂授權之日為止。此項增發方案尚需提交至2023年度股東大會審議。
TIANCHI LITHIUM CO., LTD. CONVENED THE BOARD OF DIRECTORS ON MARCH 27, 2024 TO APPROVE A MOTION TO EXTEND THE GENERAL MANDATES FOR H SHARES OF THE COMPANY. In order to meet the Company's business development needs, the Board of Directors and the Chairman of the Board of Directors shall decide to issue H Shares or related securities of no more than 20% of the total issued shares. The authorization includes the terms and conditions governing the issuance of new shares, such as the class of shares, the number, the pricing method, the issue date, etc. The general mandate is valid until 12 months after the approval of the 2023 General Meeting, the end of the 2024 General Meeting, or the date on which the Shareholders' Meeting revokes or amends the authorization. The expansion plan is still subject to submission for consideration at the 2023 General Meeting.
TIANCHI LITHIUM CO., LTD. CONVENED THE BOARD OF DIRECTORS ON MARCH 27, 2024 TO APPROVE A MOTION TO EXTEND THE GENERAL MANDATES FOR H SHARES OF THE COMPANY. In order to meet the Company's business development needs, the Board of Directors and the Chairman of the Board of Directors shall decide to issue H Shares or related securities of no more than 20% of the total issued shares. The authorization includes the terms and conditions governing the issuance of new shares, such as the class of shares, the number, the pricing method, the issue date, etc. The general mandate is valid until 12 months after the approval of the 2023 General Meeting, the end of the 2024 General Meeting, or the date on which the Shareholders' Meeting revokes or amends the authorization. The expansion plan is still subject to submission for consideration at the 2023 General Meeting.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more